Live and on-demand webinars
Join an upcoming webinar or view our library of on-demand recordings. From genetics 101 to genomic-based newborn screening, we’ve got you covered!
In pediatric critical care settings, patients may present with complex symptoms that do not point to a clear diagnosis. 48 hours that changed the case follows real, anonymized patient cases where ultraRapid genome sequencing helped uncover genomic answers in just 48 hours.
Hosted by Dr. Linda Genen, each episode examines one case, the diagnostic uncertainty clinicians faced, and how earlier genomic insights helped care teams make more informed care decisions. From cases involving neurologic, metabolic, cardiac, and other complex presentations, the series highlights the clinical value of knowing sooner.
Register once to receive every episode delivered directly to your inbox before it is released.
Upcoming webinars
In this webinar, attendees will explore genetic testing strategies for children and young adults with epilepsy, with insights relevant to pediatricians, pediatric and adult neurologists, geneticists, genetic counselors, developmental behavioral pediatricians and other clinicians involved in diagnostic evaluation.
Arie Weinstock, Professor of Clinical Neurology at the State University of New York at Buffalo and Director of the Epilepsy Program and Long-Term Monitoring at Oishei Children’s Hospital, will use pediatric and young adult neurology cases to illustrate how genetic testing, including genomic sequencing with trio analysis (parental samples), can help identify the underlying cause of disease. A genetic diagnosis can end the diagnostic odyssey and allow tailored therapy.
Rare disease research begins with understanding the underlying biology. GeneDx Infinity - the world's largest clinically interpreted rare disease database - combines clinically generated genomic data and expert interpretation to help biopharma identify the right patients and better understand disease biology. When linked with Komodo Health's longitudinal claims-based data, researchers gain a more complete view of the patient journey, connecting genetic insights to treatment patterns, healthcare utilization, and long-term outcomes.
Join experts from GeneDx and Komodo Health to explore how integrated genomic and claims-based data can improve patient finding, enable more precise rare disease cohorts, and generate higher-confidence real-world evidence across the drug development lifecycle. The session will also demonstrate how GeneDx Infinity and Komodo's AI-first capabilities, including Marmot, help transform complex datasets into actionable insights for discovery, clinical development, and post-launch evidence generation.
Past webinars
Speakers:
Danny Mitchell, MS, CGC; Dawan King, MD
Moderator:
Olivia Trimmier, MS, CGC
Description:
This session provides a practical overview of genetic testing for children with GDD and ID, including how to identify patients who may benefit, the role of exome (+CMA) and genome sequencing, and how results can help guide care and next steps—paired with real-world perspective from a practicing pediatrician.
During this session we will:
- Describe how to identify patients who may benefit from genetic testing based on clinical presentation
- Explain the role of exome (+CMA) and genome sequencing as first-line testing options in pediatric care
- Discuss the value of genetic testing for patients, including its impact on care management, and review available clinical resources and advocacy organizations to support testing
- Share real-world insights from Dr. Dawan King on implementing genetic testing in clinical practice, including her experience and case examples
This webinar will provide nurses with a practical, clinically relevant overview of genetic testing in pediatric neurology, emphasizing its role in shortening the diagnostic odyssey and informing patient management.
Speakers: Sophia Ceulemans, MS, LCGC and Jordyn Wiser, DNP, ARNP, CPNP-PC
Moderator: Lindsay Fosler, MS, CGC
During this webinar we will:
- Describe the role of genetic testing in pediatric neurology and its impact on time to diagnosis, patient management, treatment planning, and outcomes
- Identify common clinical indications for genetic testing, including epilepsy and neurodevelopmental disorders
- Compare the benefits and limitations of genetic testing options, including gene panels, chromosomal microarray, exome sequencing, and genome sequencing
- Share real‑world insights from a featured nurse speaker on integrating genetic testing into clinical workflows, including patient education, care coordination, and collaboration with the multidisciplinary team.
This CEU webinar will explore the role of exome sequencing as a first‑tier test for individuals with seizures, using real‑world clinical evidence. The session will cover the impact of genomic sequencing on healthcare resource utilization and total healthcare costs, as well as the current treatment landscape and emerging precision medicine approaches in pediatric epilepsy
Ready to bring genetic testing into your practice?
We’re here to support every step.